SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xinyan Zhang, Camlin Tierney, Mary Albrecht, Lisa M. Demeter, Gene Morse, Robin DiFrancesco, Carrie Dykes, Hongyu Jiang, David W. Haas, Discordant Associations Between SLCO1B1 521T→C and Plasma Levels of Ritonavir-boosted Protease Inhibitors in AIDS Clinical Trials Group Study A5146, Therapeutic Drug Monitoring, 2013, 35, 2, 209

    CrossRef

  2. You have free access to this content2
    Ming-Liang Lai, Yu-En Tien, Ying-Syuan Huang, Jin-Ding Huang, Studies on pharmacokinetic mechanism of phenytoin resistance in refractory epilepsy, Journal of Pharmaceutical Sciences, 2013, 102, 9
  3. 3
    Bastien Rance, Emily Doughty, Dina Demner-Fushman, Maricel G. Kann, Olivier Bodenreider, A mutation-centric approach to identifying pharmacogenomic relations in text, Journal of Biomedical Informatics, 2012, 45, 5, 835

    CrossRef

  4. 4
    In-Wha Kim, Hwi-yeol Yun, Boyoon Choi, Nayoung Han, Seon-Yang Park, Eun Sook Lee, Jung Mi Oh, ABCB1 C3435T Genetic Polymorphism on Population Pharmacokinetics of Methotrexate After Hematopoietic Stem Cell Transplantation in Korean Patients: A Prospective Analysis, Clinical Therapeutics, 2012, 34, 8, 1816

    CrossRef

  5. 5
    Renier Myburgh, Warren E. Hochfeld, Tyren M. Dodgen, James Ker, Michael S. Pepper, Cardiovascular pharmacogenetics, Pharmacology & Therapeutics, 2012, 133, 3, 280

    CrossRef

  6. 6
    Yurong Lai, Manthena Varma, Bo Feng, Joel Clay Stephens, Emi Kimoto, Ayman El-Kattan, Katsuomi Ichikawa, Hironori Kikkawa, Chiho Ono, Akiyuki Suzuki, Misaki Suzuki, Yuichi Yamamoto, Larry Tremaine, Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 6, 723

    CrossRef

  7. 7
    Jasmine A. Talameh, David E. Lanfear, Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges, Current Heart Failure Reports, 2012, 9, 1, 23

    CrossRef

  8. You have free access to this content8
    XIANGNING MENG, GENG WANG, PENG LIU, JINGMEI HOU, YAN JIN, YANG YU, JING BAI, FENG CHEN, WENJING SUN, SONGBIN FU, ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells, Respirology, 2011, 16, 8
  9. 9
    Joseph D. Ma, Shirley M. Tsunoda, Joseph S. Bertino, Meghana Trivedi, Keola K. Beale, Anne N. Nafziger, Evaluation of In Vivo P-Glycoprotein Phenotyping Probes, Clinical Pharmacokinetics, 2010, 49, 4, 223

    CrossRef

  10. 10
    Lijuan Liu, Lan Fan, Xiangdong Peng, Dongli Hu, Honghao Zhou, MDR1 C2005T polymorphism changes substrate specificity, Cancer Chemotherapy and Pharmacology, 2010, 66, 3, 617

    CrossRef

  11. 11
    K. L. MEALEY, D. WAITING, D. L. RAUNIG, K. R. SCHMIDT, F. R. NELSON, Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Δ and ABCB1 wild type dogs, Journal of Veterinary Pharmacology and Therapeutics, 2010, 33, 5
  12. 12
    Marie Westerlund, Andrea Carmine Belin, Anna Anvret, Anna Håkansson, Hans Nissbrandt, Charlotta Lind, Olof Sydow, Lars Olson, Dagmar Galter, Association of a polymorphism in the ABCB1 gene with Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 6, 422

    CrossRef

  13. 13
    Stephanie Chhun, Celine Verstuyft, Nathalie Rizzo-Padoin, Guy Simoneau, Laurent Becquemont, Ilana Peretti, Alan Swaisland, Robert Wortelboer, Jean Francois Bergmann, Stephane Mouly, Gefitinib–phenytoin interaction is not correlated with the 14C-erythromycin breath test in healthy male volunteers, British Journal of Clinical Pharmacology, 2009, 68, 2
  14. 14
    Tabassome Simon, Céline Verstuyft, Murielle Mary-Krause, Lina Quteineh, Elodie Drouet, Nicolas Méneveau, P. Gabriel Steg, Jean Ferrières, Nicolas Danchin, Laurent Becquemont, Genetic Determinants of Response to Clopidogrel and Cardiovascular Events, New England Journal of Medicine, 2009, 360, 4, 363

    CrossRef

  15. 15
    Xiao-Jing He, Li-Mei Zhao, Feng Qiu, Ya-Xin Sun, Jesse Li-Ling, Influence of ABCB1 gene polymorphisms on the pharmacokinetics of azithromycin among healthy Chinese Han ethnic subjects, Pharmacological Reports, 2009, 61, 5, 843

    CrossRef

  16. 16
    Li-Mei Zhao, Xiao-Jing He, Feng Qiu, Ya-Xin Sun, Jesse Li-Ling, Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects, British Journal of Clinical Pharmacology, 2009, 68, 3
  17. 17
    Albert-Jan L.H.J. Aarnoudse, Jeanne P. Dieleman, Loes E. Visser, Pascal P. Arp, Ilse P. van der Heiden, Ron H.N. van Schaik, Mariam Molokhia, Albert Hofman, André G. Uitterlinden, Bruno H.Ch. Stricker, Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration, Pharmacogenetics and Genomics, 2008, 18, 4, 299

    CrossRef

  18. 18
    Marie Westerlund, Andrea Carmine Belin, Lars Olson, Dagmar Galter, Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients, Cell and Tissue Research, 2008, 334, 2, 179

    CrossRef

  19. 19
    Ying Huang, Sravan Penchala, Anh-Nhan Pham, Jeffrey Wang, Genetic variations and gene expression of transporters in drug disposition and response, Expert Opinion on Drug Metabolism & Toxicology, 2008, 4, 3, 237

    CrossRef

  20. 20
    Shruti Sharma, Mitashree Das, Ashok Kumar, Vishal Marwaha, Subramanian Shankar, Ritu Aneja, Rahul Grover, Vivek Arya, Varun Dhir, Rajiva Gupta, Uma Kumar, Ramesh C. Juyal, Thelma B.K., Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians, Pharmacogenetics and Genomics, 2008, 18, 12, 1041

    CrossRef

  21. 21
    G D Leschziner, T Andrew, M Pirmohamed, M R Johnson, ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research, The Pharmacogenomics Journal, 2007, 7, 3, 154

    CrossRef

  22. 22
    Caroline Solas, Nicolas Simon, Marie-Pierre Drogoul, Sylvie Quaranta, Véronique Frixon-Marin, Véronique Bourgarel-Rey, Corinne Brunet, Jean-Albert Gastaut, Alain Durand, Bruno Lacarelle, Isabelle Poizot-Martin, Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients, British Journal of Clinical Pharmacology, 2007, 64, 3
  23. 23
    Guillermo Gervasini, Juan Antonio Carrillo, Montserrat Garcia, Carmen San Jose, Agustin Cabanillas, Julio Benitez, Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer, Cancer, 2006, 107, 12
  24. 24
    Ho-Cheol Ryu, Hyog-Young Kwon, II-Kuen Choi, Dong-Kown Rhee, Analyses of single nucleotide polymorphisms and haplotype linkage of the humanABCB1 (MDR1) gene in Korean, Archives of Pharmacal Research, 2006, 29, 12, 1132

    CrossRef

  25. 25
    Mei-Ling Chen, Ethnic or Racial Differences Revisited, Clinical Pharmacokinetics, 2006, 45, 10, 957

    CrossRef

  26. 26
    Reinhold Kerb, Implications of genetic polymorphisms in drug transporters for pharmacotherapy, Cancer Letters, 2006, 234, 1, 4

    CrossRef

  27. 27
    Alison A. Motsinger, Marylyn D. Ritchie, Robert W. Shafer, Gregory K. Robbins, Gene D. Morse, Line Labbe´, Grant R. Wilkinson, David B. Clifford, Richard T. DʼAquila, Victoria A. Johnson, Richard B. Pollard, Thomas C. Merigan, Martin S. Hirsch, John P. Donahue, Richard B. Kim, David W. Haas, Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study, Pharmacogenetics and Genomics, 2006, 16, 11, 837

    CrossRef

  28. 28
    T. M. Bosch, V. D. Doodeman, P. H. M. Smits, I Meijerman, J. H. M. Schellens, J. H. Beijnen, Pharmacogenetic Screening for Polymorphisms in Drug-Metabolizing Enzymes and Drug Transporters in a Dutch Population, Molecular Diagnosis & Therapy, 2006, 10, 3, 175

    CrossRef

  29. 29
    S. R. Novoa, P. Barreiro, A. Rendon, A. Barrios, A. Corral, I. Jimenez-Nacher, J. Gonzalez-Lahoz, V. Soriano, Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1, Clinical Infectious Diseases, 2006, 42, 2, 291

    CrossRef

  30. 30
    Ingolf Cascorbi, Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs, Pharmacology & Therapeutics, 2006, 112, 2, 457

    CrossRef

  31. 31
    Surajit Dey, Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition, Expert Opinion on Drug Delivery, 2006, 3, 1, 23

    CrossRef

  32. 32
    Guillermo Gervasini, Sonia Vizcaino, Juan Antonio Carrillo, Maria Jesus Caballero, Julio Benitez, The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine: a pilot study, British Journal of Clinical Pharmacology, 2006, 62, 2
  33. 33
    Ana Alfirevic, B Park, Pharmacogenetics, 2006,

    CrossRef

  34. 34
    Gwo-Tzer Ho, Elaine R. Nimmo, Albert Tenesa, Janice Fennell, Hazel Drummond, Craig Mowat, Ian D. Arnott, Jack Satsangi, Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis, Gastroenterology, 2005, 128, 2, 288

    CrossRef

  35. 35
    Wendy S. Putnam, Jonathan M. Woo, Yong Huang, Leslie Z. Benet, Effect of the MDR1 C3435T Variant and P-Glycoprotein Induction on Dicloxacillin Pharmacokinetics, The Journal of Clinical Pharmacology, 2005, 45, 4
  36. 36
    Aki Sakurai, Ai Tamura, Yuko Onishi, Toshihisa Ishikawa, Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications, Expert Opinion on Pharmacotherapy, 2005, 6, 14, 2455

    CrossRef

  37. 37
    Toshiyuki SAKAEDA, MDR1 Genotype-related Pharmacokinetics: Fact or Fiction?, Drug Metabolism and Pharmacokinetics, 2005, 20, 6, 391

    CrossRef

  38. 38
    Erin R Lepper, Kees Nooter, Jaap Verweij, Milin R Acharya, William D Figg, Alex Sparreboom, Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2, Pharmacogenomics, 2005, 6, 2, 115

    CrossRef

  39. 39
    Balram Chowbay, Huihua Li, Machin David, Yin Bun Cheung, Edmund J. D. Lee, Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression, British Journal of Clinical Pharmacology, 2005, 60, 2
  40. 40
    I. E. L. M. Kuppens, T. M. Bosch, M. J. Maanen, H. Rosing, A. Fitzpatrick, J. H. Beijnen, J. H. M. Schellens, Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093), Cancer Chemotherapy and Pharmacology, 2005, 55, 1, 72

    CrossRef

  41. 41
    Jill S Warrington, Leslie M Shaw, Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy, Expert Opinion on Drug Metabolism & Toxicology, 2005, 1, 3, 487

    CrossRef

  42. 42
    Michiya Kobayashi, Hiroshi Saitoh, Michiko Yamaguchi, Takeshi Saito, Hiroyoshi Fujita, Manabu Suno, Kazuo Matsubara, Bruce J. Aungst, Relationship Between Loperamide-Induced Sedative Effect and Digoxin Pharmacokinetics in Healthy Japanese Subjects, Pharmaceutical Research, 2005, 22, 3, 413

    CrossRef

  43. 43
    Dennis A Hesselink, Teun van Gelder, Ron HN van Schaik, The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?, Pharmacogenomics, 2005, 6, 4, 323

    CrossRef

  44. 44
    Catia Marzolini, Richard Kim, Rommel Tirona, Pharmacogenomics, Second Edition, 2005,

    CrossRef

  45. 45
    Toshihisa ISHIKAWA, Hiroyuki HIRANO, Yuko ONISHI, Aki SAKURAI, Shigeki TARUI, Functional Evaluation of ABCB1 (P-Glycoprotein) Polymorphisms: High-Speed Screening and Structure-Activity Relationship Analyses, Drug Metabolism and Pharmacokinetics, 2004, 19, 1, 1

    CrossRef

  46. 46
    Joseph Prandota, Limitations in the Clinical Usefulness of Single-Dose Pharmacokinetic Studies of Drugs and a Bayesian Approach for the Estimation of Kinetic Parameters, American Journal of Therapeutics, 2004, 11, 4, 295

    CrossRef

  47. 47
    Ingrid Mai, Elke S. Perloff, Steffen Bauer, Mark Goldammer, Andreas Johne, Guido Filler, Klemens Budde, Ivar Roots, MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients, British Journal of Clinical Pharmacology, 2004, 58, 5
  48. 48
    Toshihisa Ishikawa, Yuko Onishi, Hiroyuki Hirano, Keisuke Oosumi, Makoto Nagakura, Shigeki Tarui, Pharmacogenomics of Drug Transporters: A New Approach to Functional Analysis of the Genetic Polymorphisms of ABCB1 (P-Glycoprotein/MDR1), Biological & Pharmaceutical Bulletin, 2004, 27, 7, 939

    CrossRef

  49. 49
    Noboru Okamura, Toshiyuki Sakaeda, Katsuhiko Okumura, Pharmacogenomics of MDR and MRP subfamilies, Personalized Medicine, 2004, 1, 1, 85

    CrossRef

  50. 50
    Lauretta M.S Chan, Simon Lowes, Barry H Hirst, The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability, European Journal of Pharmaceutical Sciences, 2004, 21, 1, 25

    CrossRef

  51. 51
    Toshihisa Ishikawa, Akira Tsuji, Kenichi Inui, Yoshimichi Sai, Naohiko Anzai, Morimasa Wada, Hitoshi Endou, Yasuhiro Sumino, The genetic polymorphism of drug transporters: functional analysis approaches, Pharmacogenomics, 2004, 5, 1, 67

    CrossRef

  52. 52
    Monika Hitzl, Elke Schaeffeler, Berthold Hocher, Torsten Slowinski, Horst Halle, Michel Eichelbaum, Peter Kaufmann, Peter Fritz, Martin F Fromm, Matthias Schwab, Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1), Pharmacogenetics, 2004, 14, 5, 309

    CrossRef

  53. 53
    Jashvant Unadkat, Xiaoxiong Wei, New Drug Development, 2004,

    CrossRef

  54. 54
    Mary F Hebert, Amy LS Dowling, Cynthia Gierwatowski, Yvonne S Lin, Karen L Edwards, Connie L Davis, Christopher L Marsh, Erin G Schuetz, Kenneth E Thummel, Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors, Pharmacogenetics, 2003, 13, 11, 661

    CrossRef

  55. 55
    Katsuhiko Saito, Sachie Miyake, Hiroyuki Moriya, Miyuki Yamazaki, Fumio Itoh, Kohzoh Imai, Nahoko Kurosawa, Eiji Owada, Atsushi Miyamoto, Detection of the four sequence variations of MDR1 gene using TaqMan® MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects, Clinical Biochemistry, 2003, 36, 7, 511

    CrossRef

  56. 56
    Tsutomu NAKAMURA, MDR1 Genotypes Related to Pharmacokinetics and MDR1 Expression, YAKUGAKU ZASSHI, 2003, 123, 9, 773

    CrossRef

  57. 57
    Ingrid Mai, Elke Störmer, Mark Goldammer, Andreas Johne, Hagen Krüger, Klemens Budde, Ivar Roots, MDR1 Haplotypes Do Not Affect the Steady-State Pharmacokinetics of Cyclosporine in Renal Transplant Patients, The Journal of Clinical Pharmacology, 2003, 43, 10
  58. 58
    Toshiyuki Sakaeda, Tsutomu Nakamura, Katsuhiko Okumura, Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs, Pharmacogenomics, 2003, 4, 4, 397

    CrossRef

  59. 59
    Alex Sparreboom, Romano Danesi, Yuichi Ando, Juliana Chan, William D. Figg, Pharmacogenomics of ABC transporters and its role in cancer chemotherapy, Drug Resistance Updates, 2003, 6, 2, 71

    CrossRef

  60. 60
    Marilyn E. Morris, Yash A. Gandhi, ABC Transporters in Intestinal and Liver Efflux,
  61. 61
    Jayanth Panyam, Yogesh Patil, Distribution: Movement of Drugs through the Body, Pharmaceutical Sciences Encyclopedia,
  62. 62
    David A. Katz, Anahita Bhathena, Overview of Pharmacogenetics, Current Protocols in Human Genetics,
  63. 63
    David A. Katz, Overview of Pharmacogenetics, Current Protocols in Pharmacology,
  64. 64
    Henriette E. Meyer zu Schwabedissen, Markus Grube, Heyo K. Kroemer, Pharmacogenetics of Drug Transporters,
  65. 65
    Anke-Hilse Maitland-van der Zee, Brian J. Puckett, Steven G. Terra, Joe Walker, SNPs: Single Nucleotide Polymorphisms and Pharmacogenomics: Individually Designed Drug Therapy, Burger's Medicinal Chemistry and Drug Discovery,